UPDATED 20.02.2014 10:14

Organised cervical cancer screening programme in Finland in the invitation year 1995. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 416 municipalities (out of 455).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 156169 1223 0.78 14 0.01 8 0.01 31 0.02 113 0.07 167 0.11 173 0.11 717 0.46
I 146173 4 0.00 - - - - - - - - - - - - 4 0.00
II 9262 494 0.32 1 0.00 1 0.00 1 0.00 14 0.01 29 0.02 59 0.04 389 0.25
III 667 663 0.42 11 0.01 6 0.00 14 0.01 73 0.05 129 0.08 113 0.07 317 0.20
IV 60 60 0.04 - - 1 0.00 16 0.01 26 0.02 9 0.01 1 0.00 7 0.00
V 2 2 0.00 2 0.00 - - - - - - - - - - - -
Inadequate 4 - - - - - - - - - - - - - - - -
Unknown 1 - - - - - - - - - - - - - - - -
HPV test 0 0 - - - - - - - - - - - - - - -
Negative1 - - - - - - - - - - - - - - - - -
Positive2 - - - - - - - - - - - - - - - - -
Total 156169 1223 0.78 14 0.01 8 0.01 31 0.02 113 0.07 167 0.11 173 0.11 717 0.46

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.